Forward Pharma A/S (Forward Pharma A/S) Notes Receivable : $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Notes Receivable?

Forward Pharma A/S's Notes Receivable for the quarter that ended in Jun. 2022 was $0.00 Mil.

Forward Pharma A/S Notes Receivable Historical Data

The historical data trend for Forward Pharma A/S's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S Notes Receivable Chart

Forward Pharma A/S Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Notes Receivable

Get a 7-Day Free Trial

Forward Pharma A/S Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Forward Pharma A/S Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Forward Pharma A/S Notes Receivable Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100

Website

https://www.forward-pharma.com

Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.